These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11730150)

  • 41. ADHD in childhood epilepsy: Clinical determinants of severity and of the response to methylphenidate.
    Rheims S; Herbillon V; Villeneuve N; Auvin S; Napuri S; Cances C; Berquin P; Castelneau P; Nguyen The Tich S; Villega F; Isnard H; Nabbout R; Gaillard S; Mercier C; Kassai B; Arzimanoglou A;
    Epilepsia; 2016 Jul; 57(7):1069-77. PubMed ID: 27237724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of OROS methylphenidate on encopresis in children with attention-deficit/hyperactivity disorder.
    Yılmaz S; Bilgiç A; Hergüner S
    J Child Adolesc Psychopharmacol; 2014 Apr; 24(3):158-60. PubMed ID: 24168715
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats.
    Kim H; Heo HI; Kim DH; Ko IG; Lee SS; Kim SE; Kim BK; Kim TW; Ji ES; Kim JD; Shin MS; Choi YW; Kim CJ
    Neurosci Lett; 2011 Oct; 504(1):35-9. PubMed ID: 21907264
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The influence of methylphenidate on the power spectrum of ADHD children - an MEG study.
    Wienbruch C; Paul I; Bauer S; Kivelitz H
    BMC Psychiatry; 2005 Jul; 5():29. PubMed ID: 16042816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stimulant treatment history predicts frontal-striatal structural connectivity in adolescents with attention-deficit/hyperactivity disorder.
    Schweren LJ; Hartman CA; Zwiers MP; Heslenfeld DJ; Franke B; Oosterlaan J; Buitelaar JK; Hoekstra PJ
    Eur Neuropsychopharmacol; 2016 Apr; 26(4):674-83. PubMed ID: 26899587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate.
    Cheon KA; Ryu YH; Kim JW; Cho DY
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):95-101. PubMed ID: 15572278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.
    Klemm E; Grünwald F; Kasper S; Menzel C; Broich K; Danos P; Reichmann K; Krappel C; Rieker O; Briele B; Hotze AL; Möller HJ; Biersack HJ
    Am J Psychiatry; 1996 Feb; 153(2):183-90. PubMed ID: 8561197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Electroencephalographic biomarkers as predictors of methylphenidate response in attention-deficit/hyperactivity disorder.
    Arns M; Vollebregt MA; Palmer D; Spooner C; Gordon E; Kohn M; Clarke S; Elliott GR; Buitelaar JK
    Eur Neuropsychopharmacol; 2018 Aug; 28(8):881-891. PubMed ID: 29937325
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular imaging genetics of methylphenidate response in ADHD and substance use comorbidity.
    Szobot CM; Roman T; Hutz MH; Genro JP; Shih MC; Hoexter MQ; Júnior N; Pechansky F; Bressan RA; Rohde LA
    Synapse; 2011 Feb; 65(2):154-9. PubMed ID: 20593420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of methylphenidate on Internet video game play in children with attention-deficit/hyperactivity disorder.
    Han DH; Lee YS; Na C; Ahn JY; Chung US; Daniels MA; Haws CA; Renshaw PF
    Compr Psychiatry; 2009; 50(3):251-6. PubMed ID: 19374970
    [TBL] [Abstract][Full Text] [Related]  

  • 51. EEG Brain Wave Activity at Rest and during Evoked Attention in Children with Attention-Deficit/Hyperactivity Disorder and Effects of Methylphenidate.
    Thomas BL; Viljoen M
    Neuropsychobiology; 2016; 73(1):16-22. PubMed ID: 26812442
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predictors of placebo response in adults with attention-deficit/hyperactivity disorder: data from 2 randomized trials of osmotic-release oral system methylphenidate.
    Buitelaar JK; Sobanski E; Stieglitz RD; Dejonckheere J; Waechter S; Schäuble B
    J Clin Psychiatry; 2012 Aug; 73(8):1097-102. PubMed ID: 22780962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
    Roessner V; Sagvolden T; Dasbanerjee T; Middleton FA; Faraone SV; Walaas SI; Becker A; Rothenberger A; Bock N
    Neuroscience; 2010 Jun; 167(4):1183-91. PubMed ID: 20211696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gender Differences in the Behavioral Symptoms and Neuropsychological Performance of Patients with Attention-Deficit/Hyperactivity Disorder Treated with Methylphenidate: A Two-Year Follow-up Study.
    Wang LJ; Chen CK; Huang YS
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):501-8. PubMed ID: 26262904
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P; Hsu HY; Chiou SS; Chao MC
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.
    Salehi B; Imani R; Mohammadi MR; Fallah J; Mohammadi M; Ghanizadeh A; Tasviechi AA; Vossoughi A; Rezazadeh SA; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):76-80. PubMed ID: 19815048
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MR imaging of the effects of methylphenidate on brain structure and function in attention-deficit/hyperactivity disorder.
    Schweren LJ; de Zeeuw P; Durston S
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1151-64. PubMed ID: 23165220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
    Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
    Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in plasma Brain-derived neurotrophic factor (BDNF) levels induced by methylphenidate in children with Attention deficit-hyperactivity disorder (ADHD).
    Amiri A; Torabi Parizi G; Kousha M; Saadat F; Modabbernia MJ; Najafi K; Atrkar Roushan Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():20-4. PubMed ID: 23933054
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum brain-derived neurotrophic factor levels in treatment-naïve boys with attention-deficit/hyperactivity disorder treated with methylphenidate: an 8-week, observational pretest-posttest study.
    Akay AP; Resmi H; Güney SA; Erkuran HÖ; Özyurt G; Sargin E; Topuzoglu A; Tufan AE
    Eur Child Adolesc Psychiatry; 2018 Jan; 27(1):127-135. PubMed ID: 28710695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.